BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17238129)

  • 1. A case study comparing a randomized withdrawal trial and a double-blind long-term trial for assessing the long-term efficacy of an antidepressant.
    Mallinckrodt C; Chuang-Stein C; McSorley P; Schwartz J; Archibald DG; Perahia DG; Detke MJ; Alphs L
    Pharm Stat; 2007; 6(1):9-22. PubMed ID: 17238129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
    Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of study design on the results of continuation studies of antidepressants.
    Zimmerman M; Posternak MA; Ruggero CJ
    J Clin Psychopharmacol; 2007 Apr; 27(2):177-81. PubMed ID: 17414242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.
    Papakostas GI; Fava M
    Eur Neuropsychopharmacol; 2009 Jan; 19(1):34-40. PubMed ID: 18823760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A continuous responder analysis from a long-term trial of duloxetine treatment for generalized anxiety disorder: implications for the randomized withdrawal relapse prevention study design.
    Llorca PM; Bodkin JA; Spann M; Ball SG; Russell JM; Ball SG
    J Clin Psychopharmacol; 2009 Feb; 29(1):96-7. PubMed ID: 19142122
    [No Abstract]   [Full Text] [Related]  

  • 9. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term effects of glatiramer acetate in multiple sclerosis].
    Brochet B
    Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorder.
    Dunner DL; Wilson M; Fava M; Kornstein S; Munoz R; O'Reardon J; Trivedi M; Wohlreich M
    Depress Anxiety; 2008; 25(5):E1-8. PubMed ID: 17621644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data management and design issues in an unmasked randomized trial of electroconvulsive therapy for relapse prevention of severe depression: the consortium for research in electroconvulsive therapy trial.
    Rasmussen KG; Knapp RG; Biggs MM; Smith GE; Rummans TA; Petrides G; Husain MM; O'Connor MK; Fink M; Kellner CH
    J ECT; 2007 Dec; 23(4):244-50. PubMed ID: 18090697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lessons learned combining N-of-1 trials to assess fibromyalgia therapies.
    Zucker DR; Ruthazer R; Schmid CH; Feuer JM; Fischer PA; Kieval RI; Mogavero N; Rapoport RJ; Selker HP; Stotsky SA; Winston E; Goldenberg DL
    J Rheumatol; 2006 Oct; 33(10):2069-77. PubMed ID: 17014022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study design to assess the safety and efficacy of on-pump versus off-pump coronary bypass grafting: the ROOBY trial.
    Novitzky D; Shroyer AL; Collins JF; McDonald GO; Lucke J; Hattler B; Kozora E; Bradham DD; Baltz J; Grover FL;
    Clin Trials; 2007; 4(1):81-91. PubMed ID: 17327248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    Septien-Velez L; Pitrosky B; Padmanabhan SK; Germain JM; Tourian KA
    Int Clin Psychopharmacol; 2007 Nov; 22(6):338-47. PubMed ID: 17917552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of treatment trials for functional gastrointestinal disorders.
    ; Irvine EJ; Whitehead WE; Chey WD; Matsueda K; Shaw M; Talley NJ; Veldhuyzen van Zanten SJ
    Gastroenterology; 2006 Apr; 130(5):1538-51. PubMed ID: 16678567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
    Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional and alternative research designs and methods in clinical pediatric psychopharmacology.
    Fava M
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1292-303. PubMed ID: 8885583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on Colchicine for Acute Pericarditis: a multicenter randomized placebo-controlled trial evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of pericarditis; study design amd rationale.
    Imazio M; Cecchi E; Ierna S; Trinchero R;
    J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):613-7. PubMed ID: 17667033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.